Education
About Us
Working with TipRanks
Follow Us
Prestige Consumer Healthcare (PBH)
NYSE:PBH
PBH Stock Chart & Stats
$61.36
-$0.15(-0.20%)
At close: 4:00 PM EST
$61.36
-$0.15(-0.20%)
Day’s Range― - ―
52-Week Range$59.51 - $90.04
Previous CloseN/A
Volume57.25K
Average Volume (3M)407.76K
Market Cap
$2.94B
Enterprise ValueN/A
Total Cash (Recent Filing)$119.11M
Total Debt (Recent Filing)$47.88M
Price to Earnings (P/E)14.4
Beta0.32
Next Earnings
Feb 05, 2026EPS Estimate
1.17Last Dividend Ex-Date
Sep 27, 2018Dividend YieldN/A
Share Statistics
EPS (TTM)1.07
Shares Outstanding49,214,172
10 Day Avg. Volume389,042
30 Day Avg. Volume407,759
Financial Highlights & Ratios
PEG Ratio7.62
Price to Book (P/B)2.33
Price to Sales (P/S)3.76
P/FCF Ratio17.56
Enterprise Value/Market Cap0.00
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Forecast
1Y Price Target
$77.75Price Target Upside26.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)4.51
Revenue Forecast (FY)$1.10B
Bulls Say, Bears Say
Bulls Say
EarningsFiscal 2026 guidance was reaffirmed for sales while the midpoint of the EPS range was raised and is now above our going-in estimate (and the Street).
Financial PerformanceSales came in 7% above our estimate (and consensus) while EPS were 10% above our forecast (and the Street).
Strategic AcquisitionsThe acquisition of Pillar5 Pharma, a key supplier for PBH's eye care products, is expected to address supply issues and is not anticipated to negatively impact the company's financials.
Bears Say
Financial GuidanceThe company lowered its financial guidance for the year due to ongoing eye care constraints, impacting expectations.
Sales PerformanceThe need to call down full-year sales and EPS guidance given the knock-on effect of said supply constraint and a recent uneven order pattern at a key retailer, and you have a recipe for a share price pullback.
Supply ConstraintsPBH reported lower-than-expected sales and earnings due to supply constraints in the eye care business, leading to a weaker performance in North America.
Prestige Consumer Healthcare News
PBH FAQ
What was Prestige Consumer Healthcare’s price range in the past 12 months?
Prestige Consumer Healthcare lowest stock price was $59.51 and its highest was $90.04 in the past 12 months.
What is Prestige Consumer Healthcare’s market cap?
Prestige Consumer Healthcare’s market cap is $2.94B.
When is Prestige Consumer Healthcare’s upcoming earnings report date?
Prestige Consumer Healthcare’s upcoming earnings report date is Feb 05, 2026 which is in 89 days.
How were Prestige Consumer Healthcare’s earnings last quarter?
Prestige Consumer Healthcare released its earnings results on Nov 06, 2025. The company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.1.
Is Prestige Consumer Healthcare overvalued?
According to Wall Street analysts Prestige Consumer Healthcare’s price is currently Undervalued.
Does Prestige Consumer Healthcare pay dividends?
Prestige Consumer Healthcare pays a Notavailable dividend of $0.475 which represents an annual dividend yield of N/A. See more information on Prestige Consumer Healthcare dividends here
What is Prestige Consumer Healthcare’s EPS estimate?
Prestige Consumer Healthcare’s EPS estimate is 1.17.
How many shares outstanding does Prestige Consumer Healthcare have?
Prestige Consumer Healthcare has 49,214,172 shares outstanding.
What happened to Prestige Consumer Healthcare’s price movement after its last earnings report?
Prestige Consumer Healthcare reported an EPS of $1.07 in its last earnings report, beating expectations of $0.97. Following the earnings report the stock price went up 2.557%.
Which hedge fund is a major shareholder of Prestige Consumer Healthcare?
Currently, no hedge funds are holding shares in PBH
Prestige Consumer Healthcare Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$77.75 (26.71% Upside)
$77.75 (26.71% Upside)
Blogger Sentiment
Bullish
PBH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 220.1K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bearish
Bullish news 0%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-20.96%
12-Months-Change
Fundamentals
Return on Equity
12.05%
Trailing 12-Months
Asset Growth
3.75%
Trailing 12-Months
Company Description
Prestige Consumer Healthcare
Prestige Consumer Healthcare (PBH) is a leading global company specializing in over-the-counter (OTC) healthcare products. The company operates in various sectors including pain relief, cold and allergy, personal care, and foot care. PBH's core offerings include well-known brands such as TheraGun, Dramamine, and Chloraseptic, among others, which cater to a wide range of consumer health needs.
PBH Company Deck
PBH Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted strong growth in e-commerce and effective cost management, along with successful market share expansion in the dental category. However, challenges with Clear Eyes supply constraints and declining revenue due to lower sales in key categories were noted. Investment in marketing and strategic acquisitions are expected to support future growth.View all PBH earnings summariesPBH Stock 12 Month Forecast
Average Price Target
$77.75
▲(26.71% Upside)
Technical Analysis
Cardinal Health
―
Henry Schein
―
McKesson
―
Owens & Minor
―
Guardian Pharmacy Services, Inc. Class A
―
Ownership Overview
1.29% Insiders
43.81% Mutual Funds
3.97% Other Institutional Investors
24.44% Public Companies and
Individual Investors